The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Aug. 25, 2020
Filed:
May. 21, 2019
Applicant:
Corsair Pharma, Inc., South San Francisco, CA (US);
Inventors:
Cyrus K. Becker, Fremont, CA (US);
Meenakshi S. Venkatraman, Fremont, CA (US);
Xiaoming Zhang, Sunnyvale, CA (US);
Assignee:
Corsair Pharma, Inc., South San Francisco, CA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 313/00 (2006.01); C07C 69/712 (2006.01); C07D 317/40 (2006.01); C07D 321/00 (2006.01); C07D 257/06 (2006.01); C07D 263/24 (2006.01); C07D 265/30 (2006.01); C07D 295/088 (2006.01); C07D 211/60 (2006.01); C07D 295/145 (2006.01); C07D 307/20 (2006.01); C07C 219/16 (2006.01); C07C 235/20 (2006.01); C07D 453/02 (2006.01); C07C 59/54 (2006.01); C07C 69/734 (2006.01); C07C 235/34 (2006.01); C07D 207/08 (2006.01); C07D 263/26 (2006.01); C07D 317/34 (2006.01); A61K 9/70 (2006.01); A61K 31/165 (2006.01); A61K 31/216 (2006.01); A61K 31/335 (2006.01); C07C 59/31 (2006.01);
U.S. Cl.
CPC ...
C07D 313/00 (2013.01); A61K 9/7023 (2013.01); A61K 31/165 (2013.01); A61K 31/216 (2013.01); A61K 31/335 (2013.01); C07C 59/31 (2013.01); C07C 59/54 (2013.01); C07C 69/712 (2013.01); C07C 69/734 (2013.01); C07C 219/16 (2013.01); C07C 235/20 (2013.01); C07C 235/34 (2013.01); C07D 207/08 (2013.01); C07D 211/60 (2013.01); C07D 257/06 (2013.01); C07D 263/24 (2013.01); C07D 263/26 (2013.01); C07D 265/30 (2013.01); C07D 295/088 (2013.01); C07D 295/145 (2013.01); C07D 307/20 (2013.01); C07D 317/34 (2013.01); C07D 317/40 (2013.01); C07D 321/00 (2013.01); C07D 453/02 (2013.01); C07C 2601/02 (2017.05); C07C 2601/14 (2017.05); C07C 2601/16 (2017.05); C07C 2602/42 (2017.05); C07C 2603/14 (2017.05);
Abstract
Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.